Hamilton Lane Incorporated acquired an unknown minority stake in Cosette Pharmaceuticals, Inc. from Avista Capital Holdings, L.P.
July 16, 2024
Share
Hamilton Lane Incorporated (NasdaqGS:HLNE) acquired an unknown minority stake in Cosette Pharmaceuticals, Inc. from Avista Capital Holdings, L.P. on July 17, 2024. In conjunction with the transaction, Cosette also entered into a new term loan financing with Hayfin Capital Management, and a new revolver provided by UBS Investment Bank, Capital One, National Association and Santander Corporate & Investment Bank, who acted as joint lead arrangers and joint bookrunners for the financing. Ropes & Gray LLP advised Avista Capital Partners and Cosette Pharmaceuticals on this transaction and Debevoise & Plimpton LLP advised Hamilton Lane.
Hamilton Lane Incorporated (NasdaqGS:HLNE) completed the acquisition of an unknown minority stake in Cosette Pharmaceuticals, Inc. from Avista Capital Holdings, L.P. on July 17, 2024.
Hamilton Lane Incorporated is a private markets investment company providing solutions to institutional and private wealth investors around the world. The Company offers a variety of investment solutions to address its clients' needs across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. These solutions are constructed from a range of investment types, including primary investments in funds managed by third-party managers, direct investments alongside such funds and acquisitions of secondary stakes in such funds, with a number of its clients utilizing multiple investment types. These solutions are offered in a variety of formats covering some or all phases of private markets investment programs, which include customized separate accounts, specialized funds, advisory services, distribution management, and reporting, monitoring, data and analytics.